Northwestern University’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,496
Closed -$2.21M 7
2024
Q3
$2.21M Hold
22,496
2.6% 3
2024
Q2
$3.69M Hold
22,496
3.97% 3
2024
Q1
$3.43M Hold
22,496
3.18% 4
2023
Q4
$7.06M Hold
22,496
6.29% 4
2023
Q3
$9.99M Sell
22,496
-22,000
-49% -$9.94M 7.72% 4
2023
Q2
$19.3M Hold
44,496
18.9% 2
2023
Q1
$26.4M Hold
44,496
23.54% 2
2022
Q4
$18M Hold
44,496
17.22% 2
2022
Q3
$26.1M Hold
44,496
25.65% 2
2022
Q2
$24.3M Hold
44,496
25.46% 2
2022
Q1
$28.2M Hold
44,496
23.37% 2
2021
Q4
$30M Hold
44,496
27.47% 2
2021
Q3
$29.2M Hold
44,496
28.46% 2
2021
Q2
$45.1M Buy
+44,496
New +$39M 37.54% 2

Other funds holding AGL

Northwestern University's AGL Position: Q4 2024 in Review

Northwestern University sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 22,496 shares — an estimated $2.21M sold.

Northwestern University first reported a position in AGL in Q2 2021 and held it in 14 quarters. The position peaked at $45.1M in Q2 2021. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • Northwestern University reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • Northwestern University sold 22,496 Agilon Health shares in Q4 2024, an estimated $2.21M.
  • Northwestern University first reported a position in Agilon Health in Q2 2021 and held it in 14 quarters.
  • Northwestern University's Agilon Health position peaked at $45.1M in Q2 2021.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Northwestern University's 13F filing for Q4 2024, filed 28 Jan 2025.